GOLDMAN SACHS GROUP INC - CORMEDIX INC ownership

CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C100. A total of 33 filers reported holding CORMEDIX INC in Q1 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORMEDIX INC
ValueSharesWeighting
Q4 2016$65,000
-72.7%
42,501
-54.9%
0.00%
Q3 2016$238,000
+49.7%
94,217
+18.2%
0.00%
Q2 2016$159,000
+18.7%
79,692
+57.7%
0.00%
Q1 2016$134,000
+91.4%
50,531
+45.3%
0.00%
Q3 2015$70,000
-73.7%
34,788
-49.3%
0.00%
Q2 2015$266,000
+10.8%
68,679
+181.6%
0.00%
Q1 2015$240,000
+990.9%
24,388
+115.2%
0.00%
Q4 2014$22,000
+4.8%
11,335
-0.4%
0.00%
Q3 2014$21,000
+10.5%
11,377
+8.5%
0.00%
Q2 2014$19,000
-56.8%
10,485
-39.7%
0.00%
Q1 2014$44,00017,4000.00%
Other shareholders
CORMEDIX INC shareholders Q1 2015
NameSharesValueWeighting ↓
Bollard Group LLC 401,920$615,0000.04%
RAY GERALD L & ASSOCIATES LTD 171,000$262,0000.04%
ELLIOTT MANAGEMENT CORP 1,500,200$2,295,0000.02%
Ahrens Investment Partners LLC 1,000$15,0000.01%
TAURUS ASSET MANAGEMENT, LLC 30,000$46,0000.01%
Private Advisor Group, LLC 98,425$173,0000.01%
GROUP ONE TRADING, L.P. 275,549$422,0000.00%
TCI Wealth Advisors, Inc. 5,450$8,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 224,701$344,0000.00%
Spot Trading L.L.C 88,500$135,0000.00%
View complete list of CORMEDIX INC shareholders